Published in Nucleic Acids Res on December 22, 2008
A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol (2009) 6.25
MicroRNA profiling: approaches and considerations. Nat Rev Genet (2012) 4.39
Characterization of microRNA expression profiles in normal and osteoarthritic human chondrocytes. BMC Musculoskelet Disord (2012) 1.17
Large scale immune profiling of infected humans and goats reveals differential recognition of Brucella melitensis antigens. PLoS Negl Trop Dis (2010) 1.08
Evaluation of a new high-dimensional miRNA profiling platform. BMC Med Genomics (2009) 1.08
An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription. Nucleic Acids Res (2011) 1.08
Circulating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologies. Front Cell Neurosci (2013) 1.04
Relative quantification: characterization of bias, variability and fold changes in mass spectrometry data from iTRAQ-labeled peptides. J Proteome Res (2011) 1.02
Serological profiling of a Candida albicans protein microarray reveals permanent host-pathogen interplay and stage-specific responses during candidemia. PLoS Pathog (2010) 0.96
Profound effect of profiling platform and normalization strategy on detection of differentially expressed microRNAs--a comparative study. PLoS One (2012) 0.96
Evaluation of normalization methods for two-channel microRNA microarrays. J Transl Med (2010) 0.90
Guidelines for the design, analysis and interpretation of 'omics' data: focus on human endometrium. Hum Reprod Update (2013) 0.89
MmPalateMiRNA, an R package compendium illustrating analysis of miRNA microarray data. Source Code Biol Med (2013) 0.84
Standards affecting the consistency of gene expression arrays in clinical applications. Cancer Epidemiol Biomarkers Prev (2010) 0.80
Ionizing radiation-induced microRNA expression changes in cultured RGC-5 cells. Mol Med Rep (2015) 0.76
Assessment of a novel multi-array normalization method based on spike-in control probes suitable for microRNA datasets with global decreases in expression. BMC Res Notes (2014) 0.75
Bioconductor: open software development for computational biology and bioinformatics. Genome Biol (2004) 143.19
miRBase: tools for microRNA genomics. Nucleic Acids Res (2007) 38.61
Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics (2002) 20.59
MicroRNA signatures in human ovarian cancer. Cancer Res (2007) 9.45
A benchmark for Affymetrix GeneChip expression measures. Bioinformatics (2004) 5.99
Analyzing micro-RNA expression using microarrays. Methods Enzymol (2006) 1.68
Comparison of normalization methods with microRNA microarray. Genomics (2008) 1.51
Using GOstats to test gene lists for GO term association. Bioinformatics (2006) 12.58
FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell (1995) 9.81
AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. Proc Natl Acad Sci U S A (1992) 5.24
Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. Int J Cancer (1995) 5.24
Chromatin profiling using targeted DNA adenine methyltransferase. Nat Genet (2001) 4.09
A Grb2-associated docking protein in EGF- and insulin-receptor signalling. Nature (1996) 3.79
Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst (1999) 3.26
Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med (1996) 3.07
Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors. Cancer Res (1995) 3.04
Mutation detection using a novel plant endonuclease. Nucleic Acids Res (1998) 2.78
BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat Genet (1996) 2.75
Specific antigen/antibody interactions measured by force microscopy. Biophys J (1996) 2.71
Project normal: defining normal variance in mouse gene expression. Proc Natl Acad Sci U S A (2001) 2.66
Widespread collaboration of Isw2 and Sin3-Rpd3 chromatin remodeling complexes in transcriptional repression. Mol Cell Biol (2001) 2.64
DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum Mol Genet (2001) 2.50
A new implementation and detailed study of breakpoint analysis. Pac Symp Biocomput (2001) 2.49
Worry about ovarian cancer risk and use of ovarian cancer screening by women at risk for ovarian cancer. Gynecol Oncol (2002) 2.41
Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer. Oncogene (2008) 2.26
Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation. Gynecol Oncol (2001) 2.20
Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies. J Natl Cancer Inst (1996) 2.17
Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat. Am J Hum Genet (1999) 2.14
Activation of the B-cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis. J Biol Chem (1995) 2.05
Proteolytic activation of the cell death protease Yama/CPP32 by granzyme B. Proc Natl Acad Sci U S A (1996) 1.90
Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma. Gynecol Oncol (2004) 1.88
Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. Oncogene (1995) 1.87
Recovery from Wernicke's aphasia: a positron emission tomographic study. Ann Neurol (1995) 1.86
Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history. Cancer Res (2001) 1.81
Using flowViz to visualize flow cytometry data. Bioinformatics (2008) 1.79
The baculovirus p35 protein inhibits Fas- and tumor necrosis factor-induced apoptosis. J Biol Chem (1995) 1.72
Identifying splits with clear separation: a new class discovery method for gene expression data. Bioinformatics (2001) 1.67
Prognostic factors influencing surgical management and outcome of gastrointestinal stromal tumours. Br J Surg (2003) 1.66
4-aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine-resistant Plasmodium falciparum. Antimicrob Agents Chemother (1996) 1.65
Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study. Am J Hum Genet (1998) 1.61
The DNA repair gene MBD4 (MED1) is mutated in human carcinomas with microsatellite instability. Nat Genet (1999) 1.56
Highly sensitive methods for quantitation of human immunodeficiency virus type 1 RNA from plasma, cells, and tissues. J Clin Microbiol (1999) 1.53
Analysis of multiple Plasmodium falciparum infections in Tanzanian children during the phase III trial of the malaria vaccine SPf66. J Infect Dis (1997) 1.52
Impaired in-vitro lymphocyte responses in patients with elevated pentachlorophenol (PCP) blood levels. Arch Environ Health (1995) 1.52
A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers. Cancer Epidemiol Biomarkers Prev (2001) 1.51
Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni Syndrome. Cancer Res (2001) 1.51
Analysis of gene expression during myc oncogene-induced lymphomagenesis in the bursa of Fabricius. Proc Natl Acad Sci U S A (2001) 1.48
Ovarian cancer biology. Semin Oncol (1991) 1.40
FOXA1 represses the molecular phenotype of basal breast cancer cells. Oncogene (2012) 1.39
Optimal conditions for synthesizing complementary DNA in the HIV-1 endogenous reverse transcriptase reaction. AIDS (1990) 1.35
Genetic system for reversible integration of DNA constructs and lacZ gene fusions into the Escherichia coli chromosome. Plasmid (2000) 1.33
Ultrashort Application Time of Penetrating Electrons: A Tool for Sterilization and Preservation of Food in the Raw State. Science (1947) 1.33
Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary. Cancer (2000) 1.32
ALT-associated PML bodies are present in viable cells and are enriched in cells in the G(2)/M phase of the cell cycle. J Cell Sci (2000) 1.30
Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening. J Med Chem (2000) 1.25
Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives. Pharmacogenetics (2001) 1.23
Identification of two candidate tumor suppressor genes on chromosome 17p13.3. Cancer Res (1996) 1.21
Cloning and characterization of human colon glyoxalase-I. J Biol Chem (1993) 1.21
A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals. Cancer Res (1996) 1.21
Stereo-controlled synthesis of prostaglandins F-2a and E-2 (dl). J Am Chem Soc (1969) 1.19
Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas. Genes Chromosomes Cancer (1997) 1.19
Use of a stochastic simulation model to identify an efficient protocol for ovarian cancer screening. Control Clin Trials (1997) 1.18
A new fast heuristic for computing the breakpoint phylogeny and experimental phylogenetic analyses of real and synthetic data. Proc Int Conf Intell Syst Mol Biol (2000) 1.18
Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2. Cancer Res (1995) 1.18
Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression. Hepatology (1997) 1.17
Genetics and ovarian carcinoma. Semin Oncol (1998) 1.17
Squamous-cell carcinoma of the duodenum as a rare cause of upper gastrointestinal bleeding. Endoscopy (2006) 1.16
CEL I enzymatic mutation detection assay. Biotechniques (2000) 1.15
Endogenous proteins controlling amyloid beta-peptide polymerization. Possible implications for beta-amyloid formation in the central nervous system and in peripheral tissues. J Biol Chem (1999) 1.14
Failure of current antibiotic first-line regimens and mortality in hospitalized patients with spontaneous bacterial peritonitis. Infection (2009) 1.14
Two distinct origins of a common BRCA1 mutation in breast-ovarian cancer families: a genetic study of 15 185delAG-mutation kindreds. Am J Hum Genet (1996) 1.14
Relationship between platinum-DNA adduct formation and removal and cisplatin cytotoxicity in cisplatin-sensitive and -resistant human ovarian cancer cells. Cancer Res (1994) 1.14
Collagen-induced proMMP-2 activation by MT1-MMP in human dermal fibroblasts and the possible role of alpha2beta1 integrins. Eur J Cell Biol (2001) 1.13
Skateboard injuries: preliminary report. Br Med J (1978) 1.12
Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort Study. AIDS (1998) 1.12
The I1307K APC mutation does not predispose to colorectal cancer in Jewish Ashkenazi breast and breast-ovarian cancer kindreds. Cancer Res (1997) 1.12
The Aachen Aphasia Test. Adv Neurol (1984) 1.11
Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines. Cancer Res (1993) 1.11
Autonomy of the epithelial phenotype in human ovarian surface epithelium: changes with neoplastic progression and with a family history of ovarian cancer. Int J Cancer (1996) 1.11
Self-assembly of beta-amyloid 42 is retarded by small molecular ligands at the stage of structural intermediates. J Struct Biol (2000) 1.11
Evidence for altered regulation of gamma-glutamylcysteine synthetase gene expression among cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines. Cancer Res (1995) 1.11
Residual HIV-RNA levels persist for up to 2.5 years in peripheral blood mononuclear cells of patients on potent antiretroviral therapy. AIDS Res Hum Retroviruses (2000) 1.10
MTrasT24, a metallothionein-ras fusion gene, modulates expression in cultured rat liver cells of two genes associated with in vivo liver cancer. Proc Natl Acad Sci U S A (1988) 1.08
Vestibular-neck interaction and transformation of sensory coordinates. J Vestib Res (1997) 1.07
Life-threatening gastrointestinal bleeding due to a jejunal lesion of Henoch-Schönlein purpura. Endoscopy (2001) 1.07
Total synthesis of prostaglandins F2-alpha and E2 as the naturally occurring forms. J Am Chem Soc (1970) 1.06
Associations of blood levels of PCB, HCHS, and HCB with numbers of lymphocyte subpopulations, in vitro lymphocyte response, plasma cytokine levels, and immunoglobulin autoantibodies. Environ Health Perspect (2001) 1.06
Disabled-2 mediates c-Fos suppression and the cell growth regulatory activity of retinoic acid in embryonic carcinoma cells. J Biol Chem (2001) 1.05
Molecular cloning and characterization of LOH11CR2A, a new gene within a refined minimal region of LOH at 11q23. Genomics (1997) 1.05
Safety tests of orgotein, an antiinflammatory protein. Toxicol Appl Pharmacol (1973) 1.04
Orgotein: a new antiinflammatory metalloprotein drug evaluation of clinical efficacy and safety in inflammatory conditions of the urinary tract. Int Urol Nephrol (1974) 1.04
Prognostic impacts of cytogenetic findings in clear cell renal cell carcinoma: gain of 5q31-qter predicts a distinct clinical phenotype with favorable prognosis. Cancer Res (2001) 1.04
Facilitation of picture naming by focal transcranial magnetic stimulation of Wernicke's area. Exp Brain Res (1998) 1.04
Reduction of Undesirable By-Effects in Products Treated by Radiation. Science (1948) 1.04
Spontaneous transformation of rat ovarian surface epithelial cells results in well to poorly differentiated tumors with a parallel range of cytogenetic complexity. Cancer Res (1994) 1.03
Identification in the human candidate tumor suppressor gene HIC-1 of a new major alternative TATA-less promoter positively regulated by p53. J Biol Chem (2000) 1.02
Identification of a zinc-finger gene at 6q25: a chromosomal region implicated in development of many solid tumors. Oncogene (1997) 1.02
Expression of OVCA1, a candidate tumor suppressor, is reduced in tumors and inhibits growth of ovarian cancer cells. Cancer Res (1999) 1.02
The functional anatomy of recovery from auditory agnosia. A PET study of sound categorization in a neurological patient and normal controls. Brain (1995) 1.00
Identification of a gene containing zinc-finger motifs based on lost expression in malignantly transformed rat ovarian surface epithelial cells. Cancer Res (1997) 0.99
A functional abnormality of the fifth component of complement (C5) from human serum of individuals with a familial opsonic defect. J Immunol (1974) 0.99
A comparison of clonogenic, microtetrazolium and sulforhodamine B assays for determination of cisplatin cytotoxicity in human ovarian carcinoma cell lines. Eur J Cancer (1993) 0.98
Dual inhibition of SRC and Aurora kinases induces postmitotic attachment defects and cell death. Oncogene (2011) 0.98
Cloning and localization of a human diphthamide biosynthesis-like protein-2 gene, DPH2L2. Genomics (1998) 0.97
"Prepairs" and repairs: different monitoring functions in aphasic language production. Brain Lang (1987) 0.95
Glutathione and drug resistance. Cancer Invest (1996) 0.95
Gene expression array testing of FFPE archival breast tumor samples: an optimized protocol for WG-DASL sample preparation. Breast Cancer Res Treat (2010) 0.95